Linkage and Association Studies of the Susceptibility Genes for Type 2 Diabetes

Acta Genetica Sinica

Volumn 33, Issue 7, 2006, Pages 573-589

  HUANG, Qing Yang ^a,b   CHENG, Meng Rong ^a   JI, Sen Lin ^a  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

association studies; candidate genes; genetics; genome wide scans; type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ARTICLE; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 8; DNA MICROARRAY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROTEOMICS;

ASSOCIATION; CHROMOSOMES, HUMAN; DIABETES MELLITUS, TYPE 2; FORECASTING; GENOME, HUMAN; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE;

EID: 33746707462     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-4172(06)60087-5     Document Type: Article

References (95)

1. O'Rahilly S., Barroso I., and Wareham N. Genetic factors in type 2 diabetes: the end of the beginning?. Science 307 (2005) 370-373
2. Hanson R., Ehm M., Pettitt D., Prochazka M., Thompson D., Timberlake D., Foroud T., Kobes S., Baier L., Burns D., Almasy L., Blangero J., Garvey W., Bennett P., and Knowler W. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63 4 (1998) 1130-1138
3. Elbein S., Hoffman M., Teng K., Leppert M., and Hasstedt S. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48 5 (1999) 1175-1182
4. Vionnet N., Hani E.-H., Dupont S., Gallina S., Francke S., Dotte S., De Matos F., Durand E., Lepretre F., Lecoeur C., Gallina P., Zekiri L., Dina C., and Froguel P. Genomewide search for type 2 diabetes-susceptibility genes in French Whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67 6 (2000) 1470-1480
5. Wiltshire S., Hattersley A., Hitman G., Walker M., Levy J., Sampson M., O'Rahilly S., Frayling T., Bell J., Lathrop G., Bennett A., Dhillon R., Fletcher C., Groves C., Jones E., Prestwich P., Simecek N., Rao P., Wishart M., Bottazzo G., Foxon R., Howell S., Smedley D., Cardon L., Menzel S., and McCarthy M. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69 3 (2001) 553-569
6. Hsueh W., St Jean P., Mitchell B., Pollin T., Knowler W., Ehm M., Bell C., Sakul H., Wagner M., Burns D., and Shuldiner A. Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the old order Amish: evidence for a new diabetes locus on chromosome 14q 11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 52 2 (2003) 550-557
7. Xiang K., Wang Y., Zheng T., Jia W., Li J., Chen L., Shen K., Wu S., Lin X., Zhang G., Wang C., Wang S., Lu H., Fang Q., Shi Y., Zhang R., Xu J., and Weng Q. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 53 1 (2004) 228-234
8. Ng M., So W., Cox N., Lam V., Cockram C., Critchley J., Bell G., and Chan J. Genome-wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 53 6 (2004) 1609-1613
9. Meigs J., Panhuysen C., Myers R., Wilson P., and Cupples L. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Off-spring Study. Diabetes 51 3 (2002) 833-840
10. Zhao J., Xiong M., Huang W., Wang H., Zuo J., Wu G., Chen Z., Qiang B., Zhang M., Chen J., Ding W., Yuan W., Xu H., Jin L., Li Y., Sun Q., Liu Q., Boer-winkle E., and Fang F. An autosomal genomic scan for loci linked to type 2 diabetes in northern Han Chinese. J Mol Med 83 3 (2005) 209-215
11. Wang H., Chu W., Das S., Ren Q., Hasstedt S., and Elbein S. Liver pyruvate kinase polymorphisms are associated with 2 diabetes in Northern European Caucasians. Diabetes 51 9 (2002) 2861-2865
12. Hanis C., Boerwinkle E., Chakraborty R., Ellsworth D., Concannon P., Stirling B., Morrison V., Wapelhorst B., Spielman R., Gogolin-Ewens K., Shepard J., Williams S., Risch N., Hinds D., Iwasaki N., Ogata M., Omori Y., Petzold C., Rietzch H., Schroder H., Schulze J., Cox N., Menzel S., Boriraj V., Chen X., Lim L., Lindner T., Mereu L., Wang Y., Xiang K., Yamagata K., Yang Y., and Bell G. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13 2 (1996) 161-166
13. Cox N., Frigge M., Nicolae D., Concannon P., Hanis C., Bell G., and Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21 2 (1999) 21-215
14. Hani E., Hager J., Philippi A., Demenais F., Froguel P., and Vionnet N. Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes 46 7 (1997) 1225-1226
15. Luo T., Zhao Y., Li G., Yuan W., Zhao J., Chen J., Huang W., and Luo M. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 44 4 (2001) 501-506
16. Francke S., Manraj M., Lacquemant C., Lecoeur C., Lepretre F., Passa P., Hebe A., Corset L., Yan S., Lahmidi S., Jankee S., Gunness T., Ramjuttun U., Balgobin V., Dina C., and Froguel P. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10 24 (2001) 2751-2765
17. Horikawa Y., Oda N., Cox N., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T., Mashima H., Schwarz P., del Bosque-Plata L., Horikawa Y., Oda Y., Yoshiuchi I., Colilla S., Polonsky K., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L., Bogardus C., Groop L., Boerwinkle E., Hanis C., and Béll G. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26 2 (2000) 163-175
18. Garant M., Kao W., Brancati F., Coresh J., Rami T., Hanis C., Boerwinkle E., and Shuldiner A. Atherosclerosis Risk in Communities Study. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 51 1 (2002) 231-237
19. Evans J., Frayling T., Cassell P., Saker P., Hitman G., Walker M., Levy J., O'Rahilly S., Rao P., Bennett A., Jones E., Menzel S., Prestwich P., Simecek N., Wishart M., Dhillon R., Fletcher C., Millward A., Demaine A., Wilkin T., Horikawa Y., Cox N., Bell G., Ellard S., McCarthy M., and Hattersley A. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69 3 (2001) 544-552
20. Cassell P., Jackson A., North B., Evans J., Syndercombe-Court D., Phillips C., Ramachandran A., Snehalatha C., Gelding S., Vijayaravaghan S., Curtis D., and Hitman G. Haplotype combination of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in south Indians. Diabetes 51 5 (2002) 1622-1628
21. Malecki M., Moczulski D., Klupa T., Wanic K., Cyganek K., Frey J., and Sieradzki J. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes in a Polish population. Eur J Endocrinol 146 5 (2002) 695-699
22. Orho-Melander M., Klannemark M., Svensson M., Ridderstrale M., Lindgren C., and Groop L. Variants in the calpain 10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51 8 (2002) 2658-2664
23. Baier L., Permana P., Yang X., Pratley R., Hanson R., Shen G., Mott D., Knowler W., Cox N., Horikawa Y., Oda N., Bell G., and Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106 7 (2000) R69-R73
24. Busfield F., Duffy D., Kesting J., Walker S., Lovelock P., Good D., Tate H., Watego D., Marczak M., Hayman N., and Shaw J. A genomewide search for type 2 diabetes-susceptibility genes in Indigenous Australians. Am J Hum Genet 70 2 (2002) 349-357
25. Weyer C., Hanson R., Tataranni P., Bogardus C., and Pratley R. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathological role of relative hyperinsulinemia. Diabetes 49 12 (2000) 2094-2101
26. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., Vatin V., Durand E., Hara K., Okada T., Tobe K., Boutin P., Kadowaki T., and Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes 51 4 (2002) 1247-1255
27. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T., Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y., Tomita M., Kimura S., Ito C., Froguel P., and Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 2 (2002) 536-540
28. Ehm M., Karnoub M., Sakul H., Gottschalk K., Holt D., Weber J., Vaske D., Briley D., Briley L., Kopf J., McMillen P., Nguyen Q., Reisman M., Lai E., Joslyn G., Shepherd N., Bell C., Wagner M., Burns D., and American Diabetes Association GENNID Study Group. Genetics of NIDDM: Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 66 6 (2000) 1871-1881
29. Lindgren C., Mahtani M., Widen E., McCarthy M., Daly M., Kirby A., Reeve M., Kruglyak L., Parker A., Meyer J., Almgren P., Lehto M., Kanninen T., Tuomi T., Groop L., and Lander E. Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 70 2 (2002) 509-516
30. Duggirala R., Blangero J., Almasy L., Dyer T., Williams K., Leach R., O'Connell P., and Stern M. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 64 4 (1999) 1127-1140
31. Permutt M., Wasson J., Suarez B., Lin J., Thomas J., Meyer J., Lewitzky S., Rennich J., Parker A., DuPrat L., Maruti S., Chayen S., and Glaser B. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50 3 (2001) 681-685
32. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., Koyama W., and Nonaka K. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40 6 (1997) 706-710
33. Brown M., Shuldiner A., Ferrell R., Weiss E., Korytkowski M., Zmuda J., McCole S., Moore G., and Hagberg J. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 50 9 (2001) 1102-1105
34. Baier L., Sacchettini J., Knowler W., Eads J., Paolisso G., Tataranni P., Mochizuki H., Bennett P., Bogardus C., and Prochazka M. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fatty oxidation, and insulin resistance. J Clin Invest 95 3 (1995) 1281-1287
35. Duggirala R., Blangero J., Almasy L., Arya R., Dyer T., Williams K., Leach R., O'Connell P., and Stern M. A major locus for fasting insulin concentration and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in non-diabetic Mexican Americans. Am J Hum Genet 68 5 (2001) 1149-1164
36. Ji L., Malecki M., Warram J., Yang Y., Rich S., and Krolewski A. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46 5 (1997) 876-881
37. Mahtani M., Widen E., Lehto M., Thomas J., McCarthy M., Brayer J., Bryant B., Chan G., Daly M., Forsblom C., Kanninen T., Kirby A., Kruglyak L., Munnelly K., Parkkonen M., Reeve-Daly M., Weaver A., Brettin T., Duyk G., Lander E., and Groop L. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 14 1 (1996) 90-94
38. Shaw J., Lovelock P., Kesting J., Cardinal J., Duffy D., Wainwright B., and Cameron D. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 47 11 (1998) 1793-1796
39. Bowden D., Sale M., Howard T., Qadri A., Spray B., Rothschild C., Akots G., Rich S., and Freedman B. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46 5 (1997) 882-886
40. Parker A., Meyer J., Lewitzky S., Rennich J., Chan G., Thomas J., Orho-Melander M., Lehtovirta M., Forsblom C., Hyrkko A., Carlsson M., Lindgren C., and Groop L. A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 50 3 (2001) 675-680
41. Rotimi C., Chen G., Adeyemo A., Furbert-Harris P., Parish-Gause D., Zhou J., Berg K., Adegoke O., Amoah A., Owusu S., Acheampong J., Agyenim-Boateng K., Eghan Jr. B., Oli J., Okafor G., Ofoegbu E., Osotimehin B., Abbiyesuku F., Johnson T., Rufus T., Fasanmade O., Kittles R., Daniel H., Chen Y., Dunston G., Collins F., and the Africa America Diabetes Mellitus (AADM) Study. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America diabetes Mellitus (AADM) study. Diabetes 53 3 (2004) 838-841
42. Bektas A., Suprenant M., Wogan L., Plengvidhya N., Rich S., Warram J., Krolewski A., and Doria A. Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes 48 11 (1999) 2246-2251
43. Ghosh S., Watanabe R., Hauser E., Valle T., Magnuson V., Erdos M., Langefeld C., Balow Jr. J., Ally D., Kohtamaki K., Chines P., Birznieks G., Kaleta H., Musick A., Te C., Tannenbaum J., Eldridge W., Shapiro S., Martin C., Witt A., So A., Chang J., Shurtleff B., Porter R., Kudelko K., Unni A., Segal L., Sharaf R., Blaschak-Harvan J., Eriksson J., Tenkula T., Vidgren G., Ehnholm C., Tuomilehto-Wolf E., Hagopian W., Buchanan T., Tuomilehto J., Bergman R., Collins F., and Boehnke M. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci USA 96 5 (1999) 2198-2203
44. Ghosh S., Watanabe R., Valle T., Hauser E., Magnuson V., Langefeld C., Ally D., Mohlke K., Silander K., Kohtamaki K., Chines P., Balow Jr J., Birznieks G., Chang J., Eldridge W., Erdos M., Karanjawala Z., Knapp J., Kudelko K., Martin C., Morales-Mena A., Musick A., Musick T., Pfahl C., Porter R., and Rayman J. The Finland-United states investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I: an autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67 5 (2000) 1174-1185
45. Silander K., Scott L., Valle T., Mohlke K., Stringham H., Wiles K., Duren W., Doheny K., Pugh E., Chines P., Narisu N., White P., Fingerlin T., Jackson A., Li C., Ghosh S., Magnuson V., Colby K., Erdos M., Hill J., Hollstein P., Humphreys K., Kasad R., Lambert J., Lazaridis K., Lin G., Morales-Mena A., Patzkowski K., Pfahl C., Porter R., Rha D., Segal L., Suh Y., Tovar J., Unni A., Welch C., Douglas J., Epstein M., Hauser E., Hagopian W., Buchanan T., Watanabe R., Bergman R., Tuomilehto J., Collins F., and Boehnke M. Finland-United Staaates Investigation of NIDDM Genetics (FUSION). A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility locus on chromosomes 6, 11, and 14. Diabetes 53 3 (2004) 821-829
46. Sale M., Freedman B., Langefeld C., Williams A., Hicks P., Colicigno C., Beck S., Brown W., Rich S., and Bowden D. A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes 53 3 (2004) 830-837
47. Arya R., Blangero J., Williams K., Almasy L., Dyer T., Leach R., O'Connell P., Stern M., and Duggirala R. Factors of insulin resistance syndrome-related phenotypes and linked to genetic locations on chromosome 6 and 7 in non-diabetic Mexican Americans. Diabetes 51 3 (2002) 841-847
48. Pizzuti A., Frittitta L., Argiolas A., Baratta R., Goldfine I., Bozzali M., Ercolino T., Scarlato G., Iacoviello L., Vigneri R., Tassi V., and Trischitta V. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48 9 (1999) 1881-1884
49. Pezzolesi M., Nam M., Nagase T., Klupa T., Dunn J., Mlynarski W., Rich S., Warram J., and Krolewski A. Examination of candidate chromosomal regions for type 2 diabetes reveals a susceptibility locus on human chromosome 8p23.1. Diabetes 53 2 (2004) 486-491
50. Xia J., Scherer S., Cohen P., Majer M., Xi T., Norman R., Knowler W., Bogardus C., and Prochazka M. A common variation in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes 47 9 (1998) 1519-1524
51. Maegawa H., Shi K., Hidaka H., Iwai N., Nishio Y., Egawa K., Kojima H., Haneda M., Yasuda H., Nakamura Y., Kinoshita M., Kikkawa R., and Kashiwagi A. The 3′-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes 48 7 (1999) 1469-1472
52. Hegele R., Harris S., Zinman B., Wang J., Cao H., Hanley A., Tsui L., and Scherer S. Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab 83 11 (1998) 3980-3983
53. Van Tilburg J., Sandkuijl L., Strengman E., van Someren H., Rigters-Aris C., Pearson P., van Haeften T., and Wijmenga C. A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel loci on 2q12 and 19q13. J Clin Endocrinol Metab 88 5 (2003) 2223-2230
54. Aulchenko Y., Vaessen N., Heutink P., Pullen J., Snijders P., Hofman A., Sandkuijl L., Houwing-Duistermaat J., Edwards M., Bennett S., Oostra B., and van Duijn C. A genome-wide search for genes involved in type 2 diabetes in a recently genetically isolated population from the Netherlands. Diabetes 52 12 (2003) 3001-3004
55. Klupa T., Malecki M., Pezzolesi M., Ji L., Curtis S., Langefeld C., Rich S., Warram J., and Krolewski A. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 49 12 (2000) 2212-2216
56. Zouali H., Hani E., Philippi A., Vionnet N., Beckmann J., Demenais F., and Froguel P. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 6 9 (1997) 1401-1408
57. Love-Gregory L., Wasson J., Ma J., Jin C., Glaser B., Suarez B., and Permutt M. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53 4 (2004) 1134-1140
58. Silander K., Mohlke K., Scott L., Peck E., Hollstein P., Skol A., Jackson A., Deloukas P., Hunt S., Stavrides G., Chines P., Erdos M., Narisu N., Conneely K., Li C., Fingerlin T., Dhanjal S., Valle T., Bergman R., Tuomilehto J., Watanabe R., Boehnke M., and Collins F. Genetic variation near the hepatocyte nuclear factor-4 gene predicts susceptibility to type 2 Diabetes. Diabetes 53 4 (2004) 1141-1149
59. Damcott C., Hoppman N., Ott S., Reinhart L., Wang J., Pollin T., O'Connell J., Mitchell B., and Shuldiner A. Polymorphisms in both promoters of hepatocyte nuclear factor 4-alpha are associated with type 2 diabetes in the Amish. Diabetes 53 12 (2004) 3337-3341
60. Weedon M., Owen K., Shields B., Hitman G., Walker M., McCarthy M., Love-Gregory L., Permutt M., Hattersley A., and Frayling T. Common variants of the hepatocyte nuclear factor-4 alpha P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 53 11 (2004) 3002-3006
61. Huang Q., Recker R., and Deng H. Searching for the osteoporosis gene(s) in the post-genome era: progress and challenge. Osteoporos Int 14 9 (2003) 701-715
62. Imperatore G., Hanson R., Pettitt D., Kobes S., Bennett P., and Knowler W. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47 5 (1998) 821-830
63. Yen C., Beamer B., Negri C., Silver K., Brown K., Yarnall D., Burns D., Roth J., and Shuldiner A. Molecular scanning of the human peroxisome proliferators activated receptor γ(h PPARγ) gene in diabetic Caucasians: Identification of a Prol2Ala PPAR 2 missense mutation. Biochem Biophys Res Commun 241 2 (1997) 270-274
64. Deeb S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., Laakso M., Fujimoto W., and Auwerx J. A Prol2Ala substitution in PPAR 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 3 (1998) 284-287
65. Douglas J., Erdos M., Watanabe R., Braun A., Johnston C., Oeth P., Mohlke K., Valle T., Ehnholm C., Buchanan T., Bergman R., Collins F., Boehnke M., and Tuomilehto J. The peroxisome proliferators activated receptor-gamma2 Prol2Ala variant: association with type 2 diabetes and trait differences. Diabetes 50 4 (2001) 886-990
66. Hara K., Okada T., Tobe K., Yasuda K., Mori Y., Kadowaki H., Hagura R., Akanuma Y., Kimura S., Ito C., and Kadowaki T. The Prol2Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271 1 (2000) 212-216
67. Mori H., Ikegami H., Kawaguchi Y., Seino S., Yokoi N., Takeda J., Inoue I., Seino Y., Yasuda K., Hanafusa T., Yamagata K., Awata T., Kadowaki T., Hara K., Yamada N., Gotoda T., Iwasaki N., Iwamoto Y., Sanke T., Nanjo K., Oka Y., Matsutani A., Maeda E., and Kasuga M. The Prol2→Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50 4 (2001) 891-894
68. Altshuler D., Hirschhorn J., Klannemark M., Lindgren C., Vohl M., Nemesh J., Lane C., Schaffner S., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T., Daly M., Groop L., and Lander E. The common PPARγ Prol2Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 1 (2000) 76-80
69. Gloyn A., Hashim Y., Ashcroft S., Ashfield R., Wiltshire S., Turner R., and UK Prospective Diabetes Study (UKPDS 53). Association studies of variants in promoter and encoding regions of beta-cell ATP sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS53). Diabetes Med 18 3 (2001) 206-212
70. Gloyn A., Weedon M., Owen K., Turner M., Knight B., Hitman G., Walker M., Levy J., Sampson M., Halford S., McCarthy M., Hattersley A., and Frayling T. Large-scale association studies of variants in genes encoding the pancreatic [beta]-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52 2 (2003) 568-572
71. + channel gene (KIR6.2/BIR):a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 41 12 (1998) 1511-1515
72. Schwanstecher C., Meyer U., and Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 51 3 (2002) 875-879
73. Huopio H., Otonkoski T., Vauhkonen I., Reimann F., Ashcroft F., and Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 361 9354 (2003) 301-307
74. Hani E., Clement K., Velho G., Vionnet N., Hager J., Philippi A., Dina C., Inoue H., Permutt M., Basdevant A., North M., Demenais F., Guy-Grand B., and Froguel P. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes 46 4 (1997) 688-694
75. Hansen T., Echwald S., Hansen L., Moller A., Almind K., Clausen J., Urhammer S., Inoue H., Ferrer J., Bryan J., Aguilar-Bryan L., Permutt M., and Pedersen O. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 47 4 (1998) 598-605
76. Inoue H., Ferrer J., Welling C., Elbein S., Hoffman M., Mayorga R., Warren-Perry M., Zhang Y., Millns H., Turner R., Province M., Bryan J., Permutt M., and Aguilar-Bryan L. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 45 6 (1996) 825-831
77. Hara K., Tobe K., Okada T., Kadowaki H., Akanuma Y., Ito C., Kimura S., and Kadowaki T. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45 5 (2002) 740-743
78. Ek J., Andersen G., Urhammer S., Gaede P., Drivsholm T., Borch-Johnsen K., Hansen T., and Pedersen O. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44 12 (2001) 2220-2226
79. Oberkofler H., Linnemayr V., Weitgasser R., Klein K., Xie M., Iglseder B., Krempler F., Paulweber B., and Patsch W. Complex haplotypes of the PGC-1 alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53 5 (2004) 1385-1393
80. Lacquemant C., Chikri M., Boutin P., Samson C., and Froguel P. No association between the G482S polymorphism of the peroxisome proliferator-activated receptor-g coactivator (PGC-1) gene and type II diabetes in French Caucasian. Diabetologia 45 4 (2002) 602-603
81. Mootha V., Lindgren C., Eriksson K., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M., Patterson N., Mesirov J., Golub T., Tamayo P., Spiegelman B., Lander E., Hirschhorn J., Altshuler D., and Groop L. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 3 (2003) 267-273
82. Cardon L., and Bell J. Association study designs for complex diseases. Nat Rev Genet 2 (2001) 91-99
83. Feakes R., Sawcer S., Chataway J., Coraddu F., Broadley S., Gray J., Jones H., Clayton D., Goodfellow P., and Compston A. Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosis. Genet Epidemiol 17 1 (1999) 51-63
84. Huang Q., Xu F., Shen H., Zhao L., Deng H., Liu Y., Dvomyk V., Conway T., Davies K., Li J., Liu Y., Recker R., and Deng H. A second stage genome scan for QTLs underlying BMD variation. Calcif Tissue Int 75 2 (2004) 138-143
85. Daly M., Rioux J., Schaffner S., Hudson T., and Lander E. High-resolution haplotype structure in the human genome. Nat Genet 29 2 (2001) 229-232
86. Patil N., Berno A., Hinds D., Barrett W., Doshi J., Hacker C., Kautzer C., Lee D., Marjoribanks C., McDonough D., Nguyen B., Norris M., Sheehan J., Shen N., Stern D., Stokowski R., Thomas D., Trulson M., Vyas K., Frazer K., Fodor S., and Cox D. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294 5547 (2001) 1719-1723
87. Stephens J., Schneider J., Tanguay D., Choi J., Acharya T., Stanley S., Jiang R., Messer C., Chew A., Han J., Duan J., Carr J., Lee M., Koshy B., Kumar A., Zhang G., Newell W., Windemuth A., Xu C., Kalbfleisch T., Shaner S., Arnold K., Schulz V., Drysdale C., Nandabalan K., Judson R., Ruano G., and Vovis G. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293 5529 (2001) 489-493
88. Meltzer P. Spotting the target: microarrays for disease gene discovery. Curr Opin Genet Develop 11 3 (2001) 258-263
89. Lawn R., Wade D., Garvin M., Wang X., Schwartz K., Porter J., Seilhamer J., Vaughan A., and Oram J. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104 8 (1999) R25-R31
90. Hanash S. Disease proteomics. Nature 422 6928 (2003) 226-232
91. Cox N., Frigge M., Nicolae D., Concannon P., Hanis C., Bell G., and Kong A. Loci on chromosomes 2 (NIDD1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nature Genet 21 2 (1999) 213-215
92. Cordell H., Wedig G., Jacobs K., and Elston R. Multilocus linkage tests based on affected relative pairs. Am J Hum Genet 66 4 (2000) 1273-1286
93. Cox N., Wapelhorst B., Morrison V., Johnson L., Pinchuk L., Spielman R., Todd J., and Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69 4 (2001) 820-830
94. Allison D., and Heo M. Meta-analysis of linkage data under worst-case conditions: a demonstration using the human OB region. Genetics 148 2 (1998) 859-865
95. The FBPP Investigators. Multi-center genetic study of hypertension: the family blood pressure program (FBPP). Hypertension 39 1 (2002) 3-9